Skip to content
10-Q

Quarterly Report

ProKidney Corp. PROK

0000950170-25-069251

← back to feed
Filed
May 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Cash And Equivalents Q1 2025 · Mar 31, 2025 $97.81M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $99.12M
Current Liabilities Q1 2025 · Mar 31, 2025 $32.81M
Current Liabilities Q1 2025 · Dec 31, 2024 $36.22M
Total Liabilities Q1 2025 · Mar 31, 2025 $36.08M
Total Liabilities Q1 2025 · Dec 31, 2024 $39.44M
Current Assets Q1 2025 · Mar 31, 2025 $359.66M
Current Assets Q1 2025 · Dec 31, 2024 $395.88M
Total Assets Q1 2025 · Mar 31, 2025 $406.06M
Total Assets Q1 2025 · Dec 31, 2024 $441.07M
Capex Q1 2025 · Mar 31, 2024 $960K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$34.65M
Stockholders Equity Q1 2025 · Mar 31, 2024 −$1.1B
Stockholders Equity Q1 2025 · Dec 31, 2023 −$1.1B
Sga Expense Q1 2025 · Mar 31, 2024 $12.84M
Rd Expense Q1 2025 · Mar 31, 2024 $27.23M
Net Income Q1 2025 · Mar 31, 2024 −$9.49M
Operating Income Q1 2025 · Mar 31, 2024 −$40.08M
Revenue Q1 2025 · Mar 31, 2024 $0